Hyperlipidaemia treatment and gut microbiology

Area of Science:

• Microbiology
• Metabolic Diseases
• Gastroenterology

Background:

• Hyperlipidemia is a significant risk factor for cardiovascular diseases.
• The gut microbiota plays a crucial role in host metabolism and health.
• Emerging evidence highlights a strong association between gut microbiota dysbiosis and hyperlipidemia.

Purpose of the Study:

• To review the intricate relationship between gut microbiota and hyperlipidemia pathogenesis.
• To explore the mechanisms by which gut microbiota influences hyperlipidemia.
• To summarize various therapeutic strategies targeting gut microbiota for hyperlipidemia treatment.

Main Methods:

• Literature review of preclinical and clinical studies.
• Analysis of research on the impact of diet, medication, and lifestyle on gut microbiota composition.
• Synthesis of data on microbiota-targeted interventions for hyperlipidemia.

Main Results:

• Gut microbiota influences lipid metabolism through various pathways, including bile acid metabolism and short-chain fatty acid production.
• Dysbiosis is consistently observed in hyperlipidemic individuals.
• Interventions modulating gut microbiota, such as probiotics, prebiotics, and fecal microbiota transplantation, show promise in managing hyperlipidemia.

Conclusions:

• The gut microbiota represents a promising therapeutic target for hyperlipidemia.
• Understanding the gut microbiota-host interactions is key to developing novel treatment strategies.
• Further research is warranted to elucidate the full potential of microbiota modulation in managing hyperlipidemia and related metabolic disorders.